Jeffrey Alan Scott
Jeffrey Alan Scott publishes mostly in Pulmonary and Respiratory Medicine, Economics and Econometrics and Oncology, on topics such as Economic and Financial Impacts of Cancer, Cancer Genomics and Diagnostics and Lung Cancer Treatments and Mutations.
- World rank
- #3,876,590 of 7,710,434 ranked researchers
- Rank in United States
- #1,063,932 of 1,627,098
- Works
- 71
- Citations
- 710
- Citations per work
- 10.0
What does Jeffrey Alan Scott research?
Jeffrey Alan Scott's work is mostly in Medicine (44%), Economics, Econometrics and Finance (19%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3143.7%
- Medicine3143.7%
- Everything else2129.9%
- Social Sciences1318.8%
- Life Sciences57.6%
- 1Pulmonary and Respiratory Medicine23% of their works
- 2Economics and Econometrics19% of their works
- 3Oncology13% of their works
- 4Cancer Research8% of their works
- 5Radiology, Nuclear Medicine and Imaging4% of their works
- 6Epidemiology4% of their works
Research topics
Which keywords describe Jeffrey Alan Scott's research?
The keywords of their largest research topics: Targeted Therapy, Cost of Care, Financial Toxicity, Quality of Life, ALK Inhibitors, Cancer Genomics, EGFR Mutations and Mutational Signatures.
- Taxanes
- Second Primary Neoplasms
- Lung Cancer
- Renal Cell Carcinoma
- Health Utility Measures
- Mutational Signatures
- Cancer Genomics
- Quality of Life
- Cost of Care
- Targeted Therapy
- Financial Toxicity
- ALK Inhibitors
- EGFR Mutations
- Cost-effectiveness Analysis
- Metastatic
- CT Screening
- Multiple Primary Cancers
- Chemotherapy-Induced Peripheral Neuropathy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Targeted Therapy282 topics
- Cost of Care231 topic
- Financial Toxicity231 topic
- Quality of Life162 topics
- ALK Inhibitors141 topic
- Cancer Genomics141 topic
- EGFR Mutations141 topic
- Mutational Signatures141 topic
- Cost-effectiveness Analysis111 topic
- Health Utility Measures111 topic
- Metastatic111 topic
- Renal Cell Carcinoma111 topic
- CT Screening81 topic
- Lung Cancer81 topic
- Multiple Primary Cancers61 topic
- Second Primary Neoplasms61 topic
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- Taxanes51 topic
Where does Jeffrey Alan Scott work?
Jeffrey Alan Scott's main affiliation in the publication record is Integra (United States), United States.
How many publications and citations does Jeffrey Alan Scott have?
OpenAlex counts 71 works and 710 citations for Jeffrey Alan Scott, an h-index of 12, ranking #3,876,590 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jeffrey Alan Scott. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.